Over the past 25+ years, Rosario LoBrutto has held progressive global leadership positions in R&D and strategy while accelerating growth in fast-paced Fortune 200/500 organizations (including Merck, Novartis, TEVA and Sandoz). Currently he is Head of Pharmaceutical Sciences and Global Expansion at Radius Health, contributing toward the mission of delivering patient-centric innovative medicines. His experience includes successfully developing and launching both innovative and generic medicines. His expertise spans API and Drug Product Development (small molecules, peptides and proteins), with a strong focus on innovation, portfolio strategy, and operational excellence. His most recent prior role at Sandoz was Head of Scientific Affairs where he advanced pipeline strategy, with responsibility for due diligence evaluations (CMC) of new opportunities for co-development, in-licensing or M&A. He oversaw external partner product development and implementation of effective regulatory and development strategies leading to timely submissions, approvals and launches.
Rosario completed his undergraduate degree in Chemistry from Drexel University and PhD in Analytical Chemistry from Seton Hall University. He has also completed his MBA from the Cornell Johnson Graduate School of Management and his MS in Health Care Policy and Leadership from the Weill Cornell Graduate School of Medical Sciences.